Figure 1 — Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity

Navigate

Research Paper|Volume 12, Issue 5|pp. 4337–4347

Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity

Back to articleFigure 1(1 of 2)

100%

Figure 1.Immunohistochemical evaluation of prostatic tissue of a patient in placebo group - lower expression of MVD (CD34), brown stained spot coloring vessels (x200).

Figure 1 — Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity | Aging